Glosgynae Limited 09712913 false 2023-12-01 2024-11-30 2024-11-30 The principal activity of the company is specialists medical practice activities. Digita Accounts Production Advanced 6.30.9574.0 true 09712913 2023-12-01 2024-11-30 09712913 2024-11-30 09712913 core:CurrentFinancialInstruments core:WithinOneYear 2024-11-30 09712913 bus:Micro-entities 2023-12-01 2024-11-30 09712913 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 09712913 bus:FilletedAccounts 2023-12-01 2024-11-30 09712913 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 09712913 bus:RegisteredOffice 2023-12-01 2024-11-30 09712913 bus:Director1 2023-12-01 2024-11-30 09712913 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 09712913 countries:EnglandWales 2023-12-01 2024-11-30 09712913 2022-12-01 2023-11-30 09712913 2023-11-30 09712913 core:CurrentFinancialInstruments core:WithinOneYear 2023-11-30 iso4217:GBP xbrli:pure

Registration number: 09712913


Prepared for the registrar
 

Glosgynae Limited

Unaudited Financial Statements

for the Year Ended 30 November 2024

 

Glosgynae Limited

(Registration number: 09712913)
Balance Sheet as at 30 November 2024

2024
£

2023
£

Fixed assets

32,971

42,255

Current assets

85,946

56,456

Creditors: Amounts falling due within one year

(24,090)

(19,645)

Net current assets

61,856

36,811

Total assets less current liabilities

94,827

79,066

Accruals and deferred income

(2,482)

(2,224)

 

92,345

76,842

Capital and reserves

92,345

76,842

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
6 Framlington Court
Libertus Road
Cheltenham
Gloucestershire
GL51 7EG

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Staff numbers

The average number of persons employed by the company (including the director) during the year, was as follows:

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

 

Glosgynae Limited

(Registration number: 09712913)
Balance Sheet as at 30 November 2024

For the financial year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

Approved and authorised by the director on 27 June 2025
 

.........................................
Dr M Vellayan
Director